Burak Ersak

19PUBLICATIONS
93CO-AUTHORS
AutoimmunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursComparative and cross-cultural education
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 10, 2026
Pelvic Wandering Spleen Mimicking an Ovarian Germ Cell Tumor.

|Nov 13, 2025
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in Turkey.

Yesim Ozkaya Ucar, Okan Aytekin, Necim Yalcin

|May 09, 2025
Survival of patients with 2014 FIGO stage IIIC high-grade serous ovarian cancer who were treated with platin-based adjuvant chemotherapy.

Mehmet Ünsal, Meltem Yücesoy, Okan Oktar

|Mar 23, 2025
The role of serum inflammatory markers in determining the severity of cervical lesions.

Ufuk Atlıhan, Onur Yavuz, Burak Ersak

|Dec 20, 2024
Surgery for patients with endometrioid-type endometrial cancer: is lymphadenectomy above the inferior mesenteric artery necessary?

Abdurrahman Alp Tokalioglu, Okan Oktar, Mehmet Unsal

|Jul 23, 2024
Impact of molecular and histopathological findings on FIGO 2009 stage I endometrial cancer: Transition to FIGO 2023 staging system.

Hande Nur Öncü, Burak Ersak, Gökçen Ege

Pageof 4

Frequent Collaborators

14 joint publications

Osman Türkmen

13 joint publications

Fatih Kılıç

12 joint publications

Taner Turan

10 joint publications

Caner Çakır